| 1 | Real World Outcomes With Chemotherapy and Immunotherapy in Metastatic Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas. (Gujarathi R, Kwock S, Abodunrin F, Setia N, Keutgen XM, Liao CY) Cancer Med 2026 Apr;15(4):e71809 |
| 1 | Cancer Testis Antigen Expression Correlates With Immune Activation and Survival in Small Bowel Neuroendocrine Tumors. (Ayabe RI, Seo YD, Melendez B, Fields BC, Diggs LP, Lazcano R, Singh BB, Wani K, Ingram D, Johnson S, Chelvanambi M, Hudgens C, Hernandez SD, Ajami NJ, Wargo JA, Lazar AJ, Knafl M, Woodman S, Halperin DM, Estrella JS, Maxwell JE) JCO Precis Oncol 2025 Jul;9:e2500107 1 Citation |
| 2 | Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline. (Perez K, Del Rivero J, Kennedy EB, Basu S, Chauhan A, Connolly HM, Dasari AN, Gangi A, Clarke CN, Hallet J, Howe JR, Grady E, Ivanidze J, Mittra ES, White SB, Raj NP, Vijayvergia N, Lewis MA, Chan JA, Kunz PL, Mailman J, Arshad J, Soares HP, Singh S, Chandrasekharan C, Soulen MC, Janson ET, Halfdanarson TR, Strosberg JR, Bergsland EK) JCO Oncol Pract 2026 Jan;22(1):19-35 23 Citations |
| 1 | Role of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) in the Treatment of Peritoneal Carcinomatosis From Small Bowel Adenocarcinoma-A Systematic Review and Meta-Analysis. (Fernando DG, Sparapani R, Mogal H) J Surg Oncol 2025 Mar;131(4):725-733 1 Citation |
| 1 | Current Status of Immunotherapy in Management of Small Bowel Neuroendocrine Tumors. (Fields BC, Ayabe RI, Seo YD, Maxwell JE, Halperin DM) Curr Oncol Rep 2024 Nov;26(11):1530-1542 4 Citations |
| 1 | ASO Practice Guidelines Series: Surgical Management of Gastrointestinal (Midgut) Neuroendocrine Neoplasms. (Hallet J, Clarke CN) Ann Surg Oncol 2024 Mar;31(3):1704-1713 12 Citations |
| 1 | Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline. (Del Rivero J, Perez K, Kennedy EB, Mittra ES, Vijayvergia N, Arshad J, Basu S, Chauhan A, Dasari AN, Bellizzi AM, Gangi A, Grady E, Howe JR, Ivanidze J, Lewis M, Mailman J, Raj N, Soares HP, Soulen MC, White SB, Chan JA, Kunz PL, Singh S, Halfdanarson TR, Strosberg JR, Bergsland EK) J Clin Oncol 2023 Nov 10;41(32):5049-5067 103 Citations |
| 1 | Stromal Lkb1 deficiency leads to gastrointestinal tumorigenesis involving the IL-11-JAK/STAT3 pathway. (Ollila S, Domènech-Moreno E, Laajanen K, Wong IP, Tripathi S, Pentinmikko N, Gao Y, Yan Y, Niemelä EH, Wang TC, Viollet B, Leone G, Katajisto P, Vaahtomeri K, Mäkelä TP) J Clin Invest 2018 Jan 02;128(1):402-414 65 Citations |
| 1 | Emerging treatment options for patients with gastroenteropancreatic neuroendocrine tumors. (Phan AT) Clin Adv Hematol Oncol 2017 Apr;15 Suppl 4(4):10-14 1 Citation |
| 1 | Recent advances in the management of gastroenteropancreatic neuroendocrine tumors: insights from the 2017 ASCO Gastrointestinal Cancers Symposium. (Iyer R, Phan AT, Boudreaux JP) Clin Adv Hematol Oncol 2017 Apr;15 Suppl 4(4):1-24 4 Citations |
| 1 | Neuroendocrine Tumors and Lanreotide Depot: Clinical Considerations and Nurse and Patient Preferences. (Ryan P, Phan AT, Adelman DT, Iwasaki M) Clin J Oncol Nurs 2016 Dec 01;20(6):E139-E146 8 Citations |
| 1 | Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study. (Caplin ME, Pavel M, Ćwikła JB, Phan AT, Raderer M, Sedláčková E, Cadiot G, Wolin EM, Capdevila J, Wall L, Rindi G, Langley A, Martinez S, Gomez-Panzani E, Ruszniewski P, CLARINET Investigators) Endocr Relat Cancer 2016 Mar;23(3):191-9 229 Citations |
| 1 | New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors. (Phan AT, Kunz PL, Reidy-Lagunes DL) Clin Adv Hematol Oncol 2015 May;13(5 Suppl 5):1-18; quiz 1 p following 18 8 Citations |
| 1 | Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors. (Shi C, Gonzalez RS, Zhao Z, Koyama T, Cornish TC, Hande KR, Walker R, Sandler M, Berlin J, Liu EH) Am J Clin Pathol 2015 Mar;143(3):398-404 77 Citations |
| 1 | Somatic mutation of CDKN1B in small intestine neuroendocrine tumors. (Francis JM, Kiezun A, Ramos AH, Serra S, Pedamallu CS, Qian ZR, Banck MS, Kanwar R, Kulkarni AA, Karpathakis A, Manzo V, Contractor T, Philips J, Nickerson E, Pho N, Hooshmand SM, Brais LK, Lawrence MS, Pugh T, McKenna A, Sivachenko A, Cibulskis K, Carter SL, Ojesina AI, Freeman S, Jones RT, Voet D, Saksena G, Auclair D, Onofrio R, Shefler E, Sougnez C, Grimsby J, Green L, Lennon N, Meyer T, Caplin M, Chung DC, Beutler AS, Ogino S, Thirlwell C, Shivdasani R, Asa SL, Harris CR, Getz G, Kulke M, Meyerson M) Nat Genet 2013 Dec;45(12):1483-6 296 Citations |
| 1 | Limitations of the SEER database for demonstrating causal relationships between treatments and outcomes in pediatric intestinal tumors. (Lal A, Lal DR) J Surg Res 2010 Jun 15;161(2):237-9 6 Citations |
| 1 | Minimally invasive resection of gastrointestinal stromal tumors. (Dholakia C, Gould J) Surg Clin North Am 2008 Oct;88(5):1009-18, vi 19 Citations |
| 1 | Inhibition of Na+/H+ exchange stimulates CCK secretion in STC-1 cells. (Prpic V, Fitz JG, Wang Y, Raymond JR, Garnovskaya MN, Liddle RA) Am J Physiol 1998 Oct;275(4):G689-95 4 Citations |
| 1 | Ameloblastoma of the maxilla with distant metastases and hypercalcemia. (Madiedo G, Choi H, Kleinman JG) Am J Clin Pathol 1981 Apr;75(4):585-91 46 Citations |
